fluoxetine has been researched along with Melanoma in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Excerpt | Relevance | Reference |
---|---|---|
"In vivo effects of the antidepressant fluoxetine on spleen antioxidant status of C57BL/6 mice were studied using a melanoma experimental model." | 7.76 | Antioxidant activity of fluoxetine: studies in mice melanoma model. ( Grygier, B; Kirkova, M; Kubera, M; Tzvetanova, E; Vircheva, S; Zamfirova, R, 2010) |
"In vivo effects of the antidepressant fluoxetine on spleen antioxidant status of C57BL/6 mice were studied using a melanoma experimental model." | 3.76 | Antioxidant activity of fluoxetine: studies in mice melanoma model. ( Grygier, B; Kirkova, M; Kubera, M; Tzvetanova, E; Vircheva, S; Zamfirova, R, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, L | 1 |
Ploessl, K | 1 |
Kung, HF | 1 |
Kirkova, M | 1 |
Tzvetanova, E | 1 |
Vircheva, S | 1 |
Zamfirova, R | 1 |
Grygier, B | 1 |
Kubera, M | 1 |
Liao, S | 1 |
Shang, J | 1 |
Tian, X | 1 |
Fan, X | 1 |
Shi, X | 1 |
Pei, S | 1 |
Wang, Q | 1 |
Yu, B | 1 |
3 other studies available for fluoxetine and Melanoma
Article | Year |
---|---|
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioi | 2013 |
Antioxidant activity of fluoxetine: studies in mice melanoma model.
Topics: Animals; Antidepressive Agents; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Fluoxetine; | 2010 |
Up-regulation of melanin synthesis by the antidepressant fluoxetine.
Topics: Animals; Antidepressive Agents; Cell Line; Cell Line, Tumor; Disease Models, Animal; Fluoxetine; Hum | 2012 |